Mr. Stilley has over two decades of experience as a life science entrepreneur and executive. Before founding Adovate, he served as CEO of Adial Pharmaceuticals, which he founded and took public.
Dr. Linden has been at the forefront of adenosine research and breakthroughs for over 40 years at the University of Virginia and the La Jolla Institute for Immunology.
Mr. Gupta is an experienced entrepreneur and executive with over a 20-year record of accomplishments commercializing novel innovations in many segments across healthcare.
Mr. Martin is a successful attorney and entrepreneur and has 25+ years of legal experience working with companies ranging from Fortune 100 companies to launching or growing technology focused start-ups.
Mr. Vinzant has over 25 years of clinical and regulatory development experience with a primary focus on increasing value for emerging pharmaceutical and biotech companies.
Dr. Thompson has over 35 years of experience in medicinal chemistry focused primarily on synthesizing adenosine analogs. He is acknowledged as a world leader in adenosine chemistry and is an inventor on over twenty issued patents.